Untargeted Metabolomics analysis of A549 treated with 0.5 mM extracellular ATP and 10 ng/ml TGF-beta
Ontology highlight
ABSTRACT: Control, 0.5 mM extracellular ATP and 10 ng/ml TGF-beta were used to treated 5 million A549 lung cancer cells in vitro for 2, 6 and 12 hours. The untargeted metabolomics analysis was performed on the cell lysates. The main objective of the study was to determine changes in metabolite abundances in lung cancer after treatment with extracellular ATP and TGF-beta (a known EMT inducer).
ORGANISM(S): Human Homo Sapiens
TISSUE(S): Lung
DISEASE(S): Cancer
SUBMITTER: Pratik Shriwas
PROVIDER: ST001779 | MetabolomicsWorkbench | Sun Apr 04 00:00:00 BST 2021
REPOSITORIES: MetabolomicsWorkbench
ACCESS DATA